These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 35577140

  • 21. Establishment and characterization of chromosomal aberrations in human cholangiocarcinoma cell lines by cross-species color banding.
    Kim DG, Park SY, You KR, Lee GB, Kim H, Moon WS, Chun YH, Park SH.
    Genes Chromosomes Cancer; 2001 Jan; 30(1):48-56. PubMed ID: 11107175
    [Abstract] [Full Text] [Related]

  • 22. Analysis of Chromosomal Alterations in Urothelial Carcinoma.
    Conconi D, Bentivegna A.
    Methods Mol Biol; 2018 Jan; 1655():3-17. PubMed ID: 28889373
    [Abstract] [Full Text] [Related]

  • 23. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
    Moeini A, Sia D, Zhang Z, Camprecios G, Stueck A, Dong H, Montal R, Torrens L, Martinez-Quetglas I, Fiel MI, Hao K, Villanueva A, Thung SN, Schwartz ME, Llovet JM.
    J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
    [Abstract] [Full Text] [Related]

  • 24. Amplification of chromosome 21q22.3 harboring trefoil factor family genes in liver fluke related cholangiocarcinoma is associated with poor prognosis.
    Muenphon K, Limpaiboon T, Jearanaikoon P, Pairojkul C, Sripa B, Bhudhisawasdi V.
    World J Gastroenterol; 2006 Jul 14; 12(26):4143-8. PubMed ID: 16830362
    [Abstract] [Full Text] [Related]

  • 25. Genetic alterations during the neoplastic cascade towards cholangiocarcinoma in primary sclerosing cholangitis.
    Kamp EJ, Dinjens WN, Doukas M, van Marion R, Verheij J, Ponsioen CY, Bruno MJ, Groot Koerkamp B, Trivedi PJ, Peppelenbosch MP, de Vries AC.
    J Pathol; 2022 Nov 14; 258(3):227-235. PubMed ID: 35897137
    [Abstract] [Full Text] [Related]

  • 26. YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma.
    Thongsom S, Chaocharoen W, Silsirivanit A, Wongkham S, Sripa B, Choe H, Suginta W, Talabnin C.
    Tumour Biol; 2016 Jul 14; 37(7):9451-63. PubMed ID: 26781979
    [Abstract] [Full Text] [Related]

  • 27. Association of NRF2 polymorphism with cholangiocarcinoma prognosis in Thai patients.
    Khunluck T, Kukongviriyapan V, Puapairoj A, Khuntikeo N, Senggunprai L, Zeekpudsa P, Prawan A.
    Asian Pac J Cancer Prev; 2014 Jul 14; 15(1):299-304. PubMed ID: 24528044
    [Abstract] [Full Text] [Related]

  • 28. Differential diagnosis of cholangiocarcinoma and IgG4-related sclerosing cholangitis by fluorescence in situ hybridization using transpapillary forceps biopsy specimens.
    Kato A, Naitoh I, Miyabe K, Hayashi K, Kondo H, Yoshida M, Kato H, Kuno T, Takahashi S, Joh T.
    J Hepatobiliary Pancreat Sci; 2018 Mar 14; 25(3):188-194. PubMed ID: 29532638
    [Abstract] [Full Text] [Related]

  • 29. Histological type of intrahepatic cholangiocarcinoma differentiated by genetic alteration from AP-PCR fingerprint.
    Chuensumran U, Saelee P, Wongkham S, Pairojkul C, Chauin S, Petmitr S.
    Asian Pac J Cancer Prev; 2011 Mar 14; 12(6):1377-80. PubMed ID: 22126467
    [Abstract] [Full Text] [Related]

  • 30. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.
    Utispan K, Thuwajit P, Abiko Y, Charngkaew K, Paupairoj A, Chau-in S, Thuwajit C.
    Mol Cancer; 2010 Jan 24; 9():13. PubMed ID: 20096135
    [Abstract] [Full Text] [Related]

  • 31. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma.
    Ahrendt SA, Eisenberger CF, Yip L, Rashid A, Chow JT, Pitt HA, Sidransky D.
    J Surg Res; 1999 Jun 01; 84(1):88-93. PubMed ID: 10334895
    [Abstract] [Full Text] [Related]

  • 32. Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma.
    Dalmasso C, Carpentier W, Guettier C, Camilleri-Broët S, Borelli WV, Campos Dos Santos CR, Castaing D, Duclos-Vallée JC, Broët P.
    BMC Cancer; 2015 Mar 14; 15():126. PubMed ID: 25879652
    [Abstract] [Full Text] [Related]

  • 33. Prognostic significance of microRNA-203 in cholangiocarcinoma.
    Li J, Gao B, Huang Z, Duan T, Li D, Zhang S, Zhao Y, Liu L, Wang Q, Chen Z, Cheng K.
    Int J Clin Exp Pathol; 2015 Mar 14; 8(8):9512-6. PubMed ID: 26464713
    [Abstract] [Full Text] [Related]

  • 34. EGFR, FLT1 and heparanase as markers identifying patients at risk of short survival in cholangiocarcinoma.
    Hoffmann AC, Goekkurt E, Danenberg PV, Lehmann S, Ehninger G, Aust DE, Stoehlmacher-Williams J.
    PLoS One; 2013 Mar 14; 8(5):e64186. PubMed ID: 23704979
    [Abstract] [Full Text] [Related]

  • 35. A novel prognostic biomarker for cholangiocarcinoma: circRNA Cdr1as.
    Jiang XM, Li ZL, Li JL, Xu Y, Leng KM, Cui YF, Sun DJ.
    Eur Rev Med Pharmacol Sci; 2018 Jan 14; 22(2):365-371. PubMed ID: 29424892
    [Abstract] [Full Text] [Related]

  • 36. Prognostic value of MUC4 for mass-forming intrahepatic cholangiocarcinoma after hepatectomy.
    Yeh CN, Pang ST, Wu RC, Chen TW, Jan YY, Chen MF.
    Oncol Rep; 2009 Jan 14; 21(1):49-56. PubMed ID: 19082442
    [Abstract] [Full Text] [Related]

  • 37. Hepatocellular and cholangiolar carcinoma-derived cell lines reveal distinct sets of chromosomal imbalances.
    Wilkens L, Hammer C, Glombitza S, Müller DE.
    Pathobiology; 2012 Jan 14; 79(3):115-26. PubMed ID: 22261732
    [Abstract] [Full Text] [Related]

  • 38. Treatments, prognostic factors, and genetic heterogeneity in advanced cholangiocarcinoma: A multicenter real-world study.
    Ottaiano A, Santorsola M, Diana A, Belli A, Lentini Graziano ML, Orefice J, Patrone R, Di Mauro A, Scognamiglio G, Tatangelo F, De Bellis M, Piccirillo M, Fiore F, Stilo S, Tarotto L, Correra M, Di Lorenzo S, Capuozzo M, Avallone A, Silvestro L, Bianco A, Granata V, Federico P, Montesarchio V, Daniele B, Izzo F, Nasti G.
    Cancer Med; 2024 Feb 14; 13(4):e6892. PubMed ID: 38457226
    [Abstract] [Full Text] [Related]

  • 39. Chromosomal aberrations in bladder cancer: fresh versus formalin fixed paraffin embedded tissue and targeted FISH versus wide microarray-based CGH analysis.
    Panzeri E, Conconi D, Antolini L, Redaelli S, Valsecchi MG, Bovo G, Pallotti F, Viganò P, Strada G, Dalprà L, Bentivegna A.
    PLoS One; 2011 Feb 14; 6(9):e24237. PubMed ID: 21909424
    [Abstract] [Full Text] [Related]

  • 40. Epidermal growth factor receptor and HER-2/neu status by immunohistochemistry and fluorescence in situ hybridization in adenocarcinomas of the biliary tree and gallbladder.
    Shafizadeh N, Grenert JP, Sahai V, Kakar S.
    Hum Pathol; 2010 Apr 14; 41(4):485-92. PubMed ID: 20040392
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.